Cargando…

Drivers and Trajectories of Resistance to New First-Line Drug Regimens for Tuberculosis

BACKGROUND: New first-line drug regimens for treatment of tuberculosis (TB) are in clinical trials: emergence of resistance is a key concern. Because population-level data on resistance cannot be collected in advance, epidemiological models are important tools for understanding the drivers and dyna...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shrestha, Sourya, Knight, Gwenan M., Fofana, Mariam, Cohen, Ted, White, Richard G., Cobelens, Frank, Dowdy, David W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281792/ https://www.ncbi.nlm.nih.gov/pubmed/25734143 http://dx.doi.org/10.1093/ofid/ofu073

Ejemplares similares

A Multistrain Mathematical Model To Investigate the Role of Pyrazinamide in the Emergence of Extensively Drug-Resistant Tuberculosis
por: Fofana, Mariam O., et al.
Publicado: (2017)

Population-Level Impact of Shorter-Course Regimens for Tuberculosis: A Model-Based Analysis
por: Fofana, Mariam O., et al.
Publicado: (2014)

The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa
por: Knight, Gwenan M., et al.
Publicado: (2015)

Implementation of Xpert MTB/RIF in Uganda: Missed Opportunities to Improve Diagnosis of Tuberculosis
por: Hanrahan, Colleen F., et al.
Publicado: (2016)

Mathematical Modeling of “Chronic” Infectious Diseases: Unpacking the Black Box
por: Fojo, Anthony T, et al.
Publicado: (2017)

Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model
por: Kendall, Emily A., et al.
Publicado: (2017)

Disease Transmission by Patients With Subclinical Tuberculosis
por: Nguyen, Hai Viet, et al.
Publicado: (2023)

How “Subclinical” is Subclinical Tuberculosis? An Analysis of National Prevalence Survey Data from Zambia( )
por: Stuck, Logan, et al.
Publicado: (2022)

Recommended First-Line Antiretroviral Therapy Regimens and Risk of Diabetes Mellitus in HIV-Infected Adults in Resource-Limited Settings
por: Paengsai, Ninutcha, et al.
Publicado: (2019)

Mathematical Modelling and Tuberculosis: Advances in Diagnostics and Novel Therapies
por: Zwerling, Alice, et al.
Publicado: (2015)

Reply to Pierce: Subclinical Tuberculosis: Some Flies in the Ointment
por: Kendall, Emily A., et al.
Publicado: (2021)

The burden of transmitted multi-drug resistance among epidemics of tuberculosis: A transmission model
por: Kendall, Emily A., et al.
Publicado: (2015)

High Rates of Recurrent Tuberculosis Disease: A Population-level Cohort Study
por: Hermans, Sabine M, et al.
Publicado: (2020)

Evaluation of Tuberculosis Treatment Response With Serial C-Reactive Protein Measurements
por: Wilson, Douglas, et al.
Publicado: (2018)

High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients
por: Hofstra, L. Marije, et al.
Publicado: (2017)

Tradeoffs in Introduction Policies for the Anti-Tuberculosis Drug Bedaquiline: A Model-Based Analysis
por: Kunkel, Amber, et al.
Publicado: (2016)

Association of First-Line and Second-Line Antiretroviral Therapy Adherence
por: Ramadhani, Habib O., et al.
Publicado: (2014)

INSTI-Based Triple Regimens in Treatment-Naïve HIV-Infected Patients Are Associated With HIV-RNA Viral Load Suppression at Ultralow Levels
por: Lambert-Niclot, Sidonie, et al.
Publicado: (2019)

Effectiveness and Pharmacokinetic Exposures of First-Line Drugs Used to Treat Drug-Susceptible Tuberculosis in Children: A Systematic Review and Meta-Analysis
por: Solans, Belén P, et al.
Publicado: (2023)

Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options
por: Meloni, Seema T, et al.
Publicado: (2017)

Predictors of Latent Tuberculosis Infection Treatment After Introduction of a New Regimen: A Retrospective Cohort Study at an Inner City Clinic
por: Yamin, Aliya, et al.
Publicado: (2016)

The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
por: Ezati, Nicholas, et al.
Publicado: (2014)

Treatment With a Three-Drug Regimen for Pulmonary Tuberculosis Based on Rapid Molecular Detection of Isoniazid Resistance: A Noninferiority Randomized Trial (FAST-TB)
por: De Castro, N, et al.
Publicado: (2022)

Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization–Recommended Weight Band Doses and Formulations
por: Chabala, Chishala, et al.
Publicado: (2021)

Drivers of Tuberculosis Transmission
por: Mathema, Barun, et al.
Publicado: (2017)

MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis
por: Kendall, Emily A., et al.
Publicado: (2017)

Anemia, Blood Transfusion Requirements and Mortality Risk in Human Immunodeficiency Virus-Infected Adults Requiring Acute Medical Admission to Hospital in South Africa
por: Kerkhoff, Andrew D., et al.
Publicado: (2015)

Modelling the synergistic effect of bacteriophage and antibiotics on bacteria: Killers and drivers of resistance evolution
por: Leclerc, Quentin J., et al.
Publicado: (2022)

Linking Individual Natural History to Population Outcomes in Tuberculosis
por: Salvatore, Phillip P, et al.
Publicado: (2018)

Drivers of COVID-19 booster uptake among nurses
por: Viskupič, Filip, et al.
Publicado: (2022)

Prevotella and Gardnerella Are Associated With Treatment Failure Following First-line Antibiotics for Bacterial Vaginosis
por: Plummer, Erica L, et al.
Publicado: (2023)

Occult Hepatitis B Virus Infection: An Old Entity With Novel Clinical Involvements
por: Malagnino, Vincenzo, et al.
Publicado: (2018)

High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis
por: Decroo, Tom, et al.
Publicado: (2020)

Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China
por: Xia, Hui, et al.
Publicado: (2020)

Efficacy of Rilpivirine-Based Regimens as Switch Therapy From Nevirapine-Based Regimens in Human Immunodeficiency Virus-Infected Patients With Virological Suppression: A Randomized Controlled Trial
por: Petchkum, Porkaew, et al.
Publicado: (2019)

Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort( )
por: Hewison, Catherine, et al.
Publicado: (2022)

Infectious and clinical tuberculosis trajectories: Bayesian modeling with case finding implications
por: Ryckman, Theresa S., et al.
Publicado: (2022)

Long-Term Mortality and Active Tuberculosis Disease Among Patients Who Were Lost to Follow-Up During Second-Line Tuberculosis Treatment in 2011–2014: Population-Based Study in the Country of Georgia
por: Kuchukhidze, Giorgi, et al.
Publicado: (2021)

Results of Early Virologic Monitoring May Facilitate Differentiated Care Monitoring Strategies for Clients on ART, Rakai, Uganda
por: Ssempijja, Victor, et al.
Publicado: (2018)

What Will It Take to Reduce HIV Incidence in the United States: A Mathematical Modeling Analysis
por: Perry, Allison, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i0ho9d846t6hsuuovtbf0nsg1g